AVITA Medical annual working capital
2019
2020
2021
2021
2022
2023
2024
2025
AVITA Medical Working Capital Growth & History (RCEL)
AVITA Medical's working capital was −$27.2M for fiscal 2025.
View full AVITA Medical company overviewAVITA Medical annual working capital history
| Fiscal year | Period ended | Working capital | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$27.2M | −$64.0M | — |
| 2024 | 2024-12-31 | $36.8M | −$54.0M | −59.43% |
| 2023 | 2023-12-31 | $90.8M | $14.0M | +18.29% |
| 2022 | 2022-12-31 | $76.8M | −$6.2M | −7.50% |
| 2021 · Dec 31 | 2021-12-31 | $83.0M | — | — |
| 2021 · Jun 30 | 2021-06-30 | $113.9M | $43.3M | +61.21% |
| 2020 | 2020-06-30 | $70.7M | $51.0M | +259.79% |
| 2019 | 2019-06-30 | $19.6M | — | — |
AVITA Medical quarterly working capital
Q4.19
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Working capital | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$40.3M | −$14.0M | — |
| Q1 2026 | 2026-03-31 | −$35.0M | −$60.0M | — |
| Q4 2025 | 2025-12-31 | −$27.2M | −$64.0M | — |
| Q3 2025 | 2025-09-30 | −$20.5M | −$67.2M | — |
| Q2 2025 | 2025-06-30 | −$26.3M | −$85.5M | — |
| Q1 2025 | 2025-03-31 | $25.0M | −$49.1M | −66.26% |
| Q4 2024 | 2024-12-31 | $36.8M | −$54.0M | −59.43% |
| Q3 2024 | 2024-09-30 | $46.8M | −$15.3M | −24.65% |
| Q2 2024 | 2024-06-30 | $59.2M | −$4.5M | −7.09% |
| Q1 2024 | 2024-03-31 | $74.1M | $2.8M | +4.00% |
| Q4 2023 | 2023-12-31 | $90.8M | $14.0M | +18.29% |
| Q3 2023 | 2023-09-30 | $62.1M | −$20.1M | −24.47% |
| Q2 2023 | 2023-06-30 | $63.7M | −$20.2M | −24.11% |
| Q1 2023 | 2023-03-31 | $71.3M | −$12.9M | −15.34% |
| Q4 2022 | 2022-12-31 | $76.8M | −$6.2M | −7.50% |
| Q3 2022 | 2022-09-30 | $82.2M | −$7.9M | −8.74% |
| Q2 2022 | 2022-06-30 | $83.9M | −$30.0M | −26.35% |
| Q1 2022 · Mar 31 | 2022-03-31 | $84.2M | −$32.5M | −27.83% |
| Q4 2021 · Dec 31 | 2021-12-31 | $83.0M | $25.4M | +44.13% |
| Q1 2022 · Sep 30 | 2021-09-30 | $90.1M | $26.4M | +41.46% |
| Q4 2021 · Jun 30 | 2021-06-30 | $113.9M | $43.3M | +61.21% |
| Q3 2021 | 2021-03-31 | $116.6M | — | — |
| Q2 2021 | 2020-12-31 | $57.6M | — | — |
| Q1 2021 | 2020-09-30 | $63.7M | — | — |
| Q4 2020 | 2020-06-30 | $70.7M | $51.0M | +259.79% |
| Q4 2019 | 2019-06-30 | $19.6M | — | — |
AVITA Medical working capital trends
Between the periods ended 2019-06-30 and 2025-12-31, AVITA Medical's working capital decreased from $19.6M to −$27.2M, a change of −$46.8M. The latest reported quarter, Q2 2026, shows −$40.3M.
About the metric
What working capital means
Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.
Calculation and source
How working capital is calculated
TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AVITA Medical source filings ↗